This is a Validated Antibody Database (VAD) review about dog SOX2, based on 63 published articles (read how Labome selects the articles), using SOX2 antibody in all methods. It is aimed to help Labome visitors find the most suited SOX2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
SOX2 synonym: transcription factor SOX-2

Invitrogen
mouse monoclonal (20G5)
  • immunohistochemistry; human; 1:50; fig 4
In order to analyze triploid breast cancers non-responsive to neoadjuvant therapy by study of aneuploidy and senescence paradoxes, Invitrogen SOX2 antibody (Pierce, MA1-014) was used in immunohistochemistry on human samples at 1:50 (fig 4). Histochem Cell Biol (2016) ncbi
mouse monoclonal (20G5)
  • western blot; human; 1:1000; fig s2
In order to discuss Phage lambda integrase as a transgenesis tool, Invitrogen SOX2 antibody (Thermo Fisher Scientific, MA1-014) was used in western blot on human samples at 1:1000 (fig s2). Nucleic Acids Res (2016) ncbi
mouse monoclonal (20G5)
  • western blot; human; fig 3a
In order to elucidate the mechanism of p53-dependent upregulation of OCT4A and p21Cip1, Invitrogen SOX2 antibody (Pierce, MA1-014) was used in western blot on human samples (fig 3a). Cell Cycle (2015) ncbi
Cell Signaling Technology
rabbit polyclonal
  • western blot; mouse; loading ...; fig 4f
Cell Signaling Technology SOX2 antibody (Cell Signaling, 2748S) was used in western blot on mouse samples (fig 4f). Mol Cell (2019) ncbi
rabbit monoclonal (D6D9)
  • flow cytometry; mouse; loading ...; fig 6g
Cell Signaling Technology SOX2 antibody (Cell Signaling, 5067) was used in flow cytometry on mouse samples (fig 6g). Mol Cell (2019) ncbi
rabbit monoclonal (D6D9)
  • immunocytochemistry; human; 1:100; loading ...; fig 4a
  • immunohistochemistry; human; 1:200; loading ...; fig 8b
  • western blot; human; 1:1000; loading ...; fig 4h
Cell Signaling Technology SOX2 antibody (Cell Signaling, 3579) was used in immunocytochemistry on human samples at 1:100 (fig 4a), in immunohistochemistry on human samples at 1:200 (fig 8b) and in western blot on human samples at 1:1000 (fig 4h). Nat Neurosci (2019) ncbi
rabbit polyclonal
  • immunocytochemistry; mouse; 1:500; loading ...; fig 4k
Cell Signaling Technology SOX2 antibody (Cell Signaling, 2748S) was used in immunocytochemistry on mouse samples at 1:500 (fig 4k). Cell (2018) ncbi
rabbit monoclonal (D6D9)
  • immunohistochemistry; human; 1:250; fig 1c
Cell Signaling Technology SOX2 antibody (Cell Signaling, D6D9) was used in immunohistochemistry on human samples at 1:250 (fig 1c). Nat Commun (2018) ncbi
rabbit polyclonal
  • other; human; loading ...; fig 4c
Cell Signaling Technology SOX2 antibody (Cell Signaling, 2748) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
rabbit monoclonal (D6D9)
  • immunohistochemistry; human; 1:160; loading ...; fig 5c
Cell Signaling Technology SOX2 antibody (Cell Signaling, 3579S) was used in immunohistochemistry on human samples at 1:160 (fig 5c). Nat Commun (2018) ncbi
rabbit monoclonal (D6D9)
  • immunocytochemistry; human; fig 5g
Cell Signaling Technology SOX2 antibody (Cell Signaling, 3579S) was used in immunocytochemistry on human samples (fig 5g). Cell (2018) ncbi
rabbit monoclonal (D6D9)
  • immunocytochemistry; human; loading ...; fig 3b
Cell Signaling Technology SOX2 antibody (Cell Signaling Technology, 3579) was used in immunocytochemistry on human samples (fig 3b). Cancer Res (2017) ncbi
rabbit monoclonal (D6D9)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 2a
  • immunocytochemistry; human; 1:200; loading ...; fig 3h
Cell Signaling Technology SOX2 antibody (Cell Signaling, 3579) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2a) and in immunocytochemistry on human samples at 1:200 (fig 3h). Nat Commun (2017) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 6h
Cell Signaling Technology SOX2 antibody (Cell Signaling Technology, 2748) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 6h). Development (2017) ncbi
rabbit monoclonal (D6D9)
  • immunohistochemistry - paraffin section; human; fig 6b
  • immunocytochemistry; human; loading ...; fig 2c
  • western blot; human; loading ...; fig 2a
In order to investigate Rac1 activity and inhibition in gastric adenocarcinoma cells and mouse xenograft models for epithelial-to-mesenchymal transition and cancer stem-like cell phenotypes, Cell Signaling Technology SOX2 antibody (Cell Signaling, 3579) was used in immunohistochemistry - paraffin section on human samples (fig 6b), in immunocytochemistry on human samples (fig 2c) and in western blot on human samples (fig 2a). Mol Cancer Res (2017) ncbi
rabbit polyclonal
  • immunocytochemistry; human; loading ...; fig 3bb
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology SOX2 antibody (Cell Signaling, 2748) was used in immunocytochemistry on human samples (fig 3bb) and in western blot on human samples (fig 2a). Mol Oncol (2017) ncbi
rabbit monoclonal (D6D9)
  • immunocytochemistry; human; fig 3b
Cell Signaling Technology SOX2 antibody (Cell signaling, 3579) was used in immunocytochemistry on human samples (fig 3b). Biol Open (2017) ncbi
rabbit monoclonal (D6D9)
  • western blot; mouse; 1:1000; loading ...; fig 3b
Cell Signaling Technology SOX2 antibody (Cell Signaling, 3579) was used in western blot on mouse samples at 1:1000 (fig 3b). J Biol Chem (2017) ncbi
rabbit monoclonal (D6D9)
  • immunohistochemistry - frozen section; human; 1:500; loading ...; fig s1b
  • western blot; human; 1:1000; loading ...; fig 2f
In order to study how the Notch-lncRNA axis mediates self-renewal of glioma cells, Cell Signaling Technology SOX2 antibody (Cell signaling, 3579) was used in immunohistochemistry - frozen section on human samples at 1:500 (fig s1b) and in western blot on human samples at 1:1000 (fig 2f). Nat Commun (2016) ncbi
rabbit monoclonal (D6D9)
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology SOX2 antibody (Cell Signaling, 3579) was used in western blot on human samples (fig 2c). Oncogene (2017) ncbi
rabbit monoclonal (D6D9)
  • immunocytochemistry; human; 1:400; fig s10b
In order to report disease-related phenotypes in human pluripotent stem cells that capture familial dysautonomia severity, Cell Signaling Technology SOX2 antibody (Cell Signaling, 3579P) was used in immunocytochemistry on human samples at 1:400 (fig s10b). Nat Med (2016) ncbi
mouse monoclonal (L73B4)
  • western blot; mouse; loading ...
In order to study the role of Yin-yang 2 in mouse embryonic stem cells, Cell Signaling Technology SOX2 antibody (Cell Signaling, 4195S) was used in western blot on mouse samples . Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (L1D6A2)
  • immunocytochemistry; human; loading ...; fig 4a
Cell Signaling Technology SOX2 antibody (CST, 4900S) was used in immunocytochemistry on human samples (fig 4a). Oncotarget (2016) ncbi
rabbit monoclonal (D6D9)
  • western blot; human; 1:1000; fig 2
In order to investigate the contribution of DNA methyltransferase 1 to the epithelial-mesenchymal transition and cancer stem cells, Cell Signaling Technology SOX2 antibody (Cell Signaling, 3579) was used in western blot on human samples at 1:1000 (fig 2). Neoplasia (2016) ncbi
mouse monoclonal (L1D6A2)
  • immunohistochemistry; mouse; 1:100; fig 2a
In order to evaluate the therapeutic potential of embryonic stem cell-derived motoneurons on reinnervation after prolonged denervation, Cell Signaling Technology SOX2 antibody (Cell Signaling, 4900) was used in immunohistochemistry on mouse samples at 1:100 (fig 2a). Ann Clin Transl Neurol (2016) ncbi
rabbit monoclonal (D6D9)
  • western blot; human; loading ...; fig 5e
In order to propose using three-dimensional collagen scaffolds to study anti-glioma therapeutics, Cell Signaling Technology SOX2 antibody (Cell Signaling, 3579P) was used in western blot on human samples (fig 5e). Oncotarget (2016) ncbi
rabbit monoclonal (D6D9)
  • western blot; human; 1:1000; loading ...; fig 2c
Cell Signaling Technology SOX2 antibody (Cell signaling, 3579) was used in western blot on human samples at 1:1000 (fig 2c). Oncotarget (2016) ncbi
rabbit monoclonal (D6D9)
  • western blot; human; 1:1000; loading ...; fig 1d
Cell Signaling Technology SOX2 antibody (Cell Signaling, 3579S) was used in western blot on human samples at 1:1000 (fig 1d). Oncotarget (2016) ncbi
mouse monoclonal (L1D6A2)
  • immunocytochemistry; human; fig 1
  • western blot; human; fig 2
Cell Signaling Technology SOX2 antibody (Cell Signaling, 4900) was used in immunocytochemistry on human samples (fig 1) and in western blot on human samples (fig 2). Stem Cells Dev (2016) ncbi
mouse monoclonal (L1D6A2)
  • immunocytochemistry; mouse; 1:50; fig s4
In order to determine that a core TFIID TATA-binding protein-associated factor is essential in differentiation events during mammalian embryogenesis, Cell Signaling Technology SOX2 antibody (Cell Signaling, L1D6A2) was used in immunocytochemistry on mouse samples at 1:50 (fig s4). Nat Commun (2016) ncbi
rabbit monoclonal (D6D9)
  • immunocytochemistry; human; 1:400; fig 2
Cell Signaling Technology SOX2 antibody (Cell Signaling, D6D9) was used in immunocytochemistry on human samples at 1:400 (fig 2). Nat Med (2016) ncbi
mouse monoclonal (L1D6A2)
  • western blot; human; fig 7
Cell Signaling Technology SOX2 antibody (Cell Singling, 4900) was used in western blot on human samples (fig 7). Oncotarget (2016) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology SOX2 antibody (Cell Signaling, 2748) was used in western blot on human samples (fig 4c). BMC Biol (2016) ncbi
rabbit monoclonal (D6D9)
  • immunohistochemistry - frozen section; human; fig 1d
  • western blot; human; 1:1000; fig 1c
Cell Signaling Technology SOX2 antibody (Cell Signaling Technology, 3579) was used in immunohistochemistry - frozen section on human samples (fig 1d) and in western blot on human samples at 1:1000 (fig 1c). J Exp Clin Cancer Res (2016) ncbi
rabbit monoclonal (D6D9)
  • western blot; human; loading ...; fig 1c
Cell Signaling Technology SOX2 antibody (Cell Signaling, 3579) was used in western blot on human samples (fig 1c). Oncotarget (2016) ncbi
rabbit polyclonal
  • western blot; mouse; 1:500; fig 3
Cell Signaling Technology SOX2 antibody (Cell Signaling, 2748) was used in western blot on mouse samples at 1:500 (fig 3). Nature (2016) ncbi
mouse monoclonal (L1D6A2)
  • immunocytochemistry; human; fig 2
  • western blot; human; fig 1
Cell Signaling Technology SOX2 antibody (Cell Signaling, 4900) was used in immunocytochemistry on human samples (fig 2) and in western blot on human samples (fig 1). PLoS ONE (2015) ncbi
rabbit polyclonal
  • western blot; human; fig 4a
In order to test if lncRNA SRA interacts with TrxG or PRC2, Cell Signaling Technology SOX2 antibody (Cell Signaling Technology, 2748S) was used in western blot on human samples (fig 4a). PLoS Genet (2015) ncbi
rabbit polyclonal
  • western blot; human; fig 2
Cell Signaling Technology SOX2 antibody (Cell signaling, 2748) was used in western blot on human samples (fig 2). Glycobiology (2016) ncbi
rabbit monoclonal (D6D9)
  • immunocytochemistry; human; 1:500; loading ...; fig 1e
In order to demonstrate that dCas9 activator controls human pluripotent stem cell differentiation into endodermal lineages, Cell Signaling Technology SOX2 antibody (Cell signaling, D6D9) was used in immunocytochemistry on human samples at 1:500 (fig 1e). Stem Cell Reports (2015) ncbi
rabbit monoclonal (D6D9)
  • western blot; mouse; loading ...; fig 1a
  • western blot; human; loading ...; fig 5d
Cell Signaling Technology SOX2 antibody (Cell Signaling, 3579) was used in western blot on mouse samples (fig 1a) and in western blot on human samples (fig 5d). Neoplasia (2015) ncbi
rabbit monoclonal (D6D9)
  • immunohistochemistry; dog; 1:50; fig 2
Cell Signaling Technology SOX2 antibody (Cell Signaling Technology, D6D9) was used in immunohistochemistry on dog samples at 1:50 (fig 2). PLoS ONE (2015) ncbi
rabbit monoclonal (D6D9)
  • immunocytochemistry; human; 1:400; fig 3
  • western blot; human; 1:1000; fig 4
Cell Signaling Technology SOX2 antibody (Cell signaling, 3579) was used in immunocytochemistry on human samples at 1:400 (fig 3) and in western blot on human samples at 1:1000 (fig 4). Oncotarget (2015) ncbi
rabbit monoclonal (D6D9)
  • immunocytochemistry; human; loading ...; fig s4d
Cell Signaling Technology SOX2 antibody (Cell Signaling, D6D9) was used in immunocytochemistry on human samples (fig s4d). Oncotarget (2015) ncbi
rabbit monoclonal (D6D9)
  • immunocytochemistry; human; 1:200; loading ...; fig 2Ac
Cell Signaling Technology SOX2 antibody (Cell Signaling Technology, 5067) was used in immunocytochemistry on human samples at 1:200 (fig 2Ac). Eur J Hum Genet (2016) ncbi
rabbit polyclonal
  • immunocytochemistry; human; fig 3
Cell Signaling Technology SOX2 antibody (Cell Signaling, 2748) was used in immunocytochemistry on human samples (fig 3). Stem Cell Res Ther (2015) ncbi
rabbit monoclonal (D6D9)
  • western blot; human; 1:500; loading ...; fig 1
Cell Signaling Technology SOX2 antibody (Cell Signaling, 3579) was used in western blot on human samples at 1:500 (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (L1D6A2)
  • immunocytochemistry; human; 1:100
Cell Signaling Technology SOX2 antibody (Cell Signaling Technology, 4900) was used in immunocytochemistry on human samples at 1:100. Int J Oncol (2015) ncbi
rabbit polyclonal
  • immunocytochemistry; human
Cell Signaling Technology SOX2 antibody (Cell Signaling, 2748) was used in immunocytochemistry on human samples . PLoS ONE (2015) ncbi
rabbit monoclonal (D6D9)
  • immunocytochemistry; human; fig 1
Cell Signaling Technology SOX2 antibody (Cell Signaling, 3579) was used in immunocytochemistry on human samples (fig 1). Thyroid (2015) ncbi
rabbit monoclonal (D6D9)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
Cell Signaling Technology SOX2 antibody (Cell Signaling, D6D9) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Hum Pathol (2015) ncbi
rabbit polyclonal
  • western blot; mouse
Cell Signaling Technology SOX2 antibody (Cell Signaling, 2748) was used in western blot on mouse samples . Science (2015) ncbi
mouse monoclonal (L1D6A2)
  • immunohistochemistry; rat; 1:100
Cell Signaling Technology SOX2 antibody (Cell Signalling Technology, L1D6A2) was used in immunohistochemistry on rat samples at 1:100. J Chem Neuroanat (2014) ncbi
mouse monoclonal (L1D6A2)
  • western blot; human
In order to investigate the role of TLR3 signaling in breast cancer stem cells, Cell Signaling Technology SOX2 antibody (cell signaling, 4900) was used in western blot on human samples . Cell Death Differ (2015) ncbi
rabbit monoclonal (D6D9)
  • immunohistochemistry - frozen section; mouse; 1:1000
Cell Signaling Technology SOX2 antibody (Cell Signaling technologies, 5024) was used in immunohistochemistry - frozen section on mouse samples at 1:1000. PLoS ONE (2014) ncbi
mouse monoclonal (L1D6A2)
  • immunocytochemistry; mouse; 1:200
Cell Signaling Technology SOX2 antibody (Cell Signaling, 4900S) was used in immunocytochemistry on mouse samples at 1:200. Cell Reprogram (2014) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:500; fig 1
Cell Signaling Technology SOX2 antibody (Cell signaling, 2748s) was used in immunocytochemistry on human samples at 1:500 (fig 1). J Biomol Screen (2014) ncbi
rabbit monoclonal (D6D9)
  • immunocytochemistry; human; 1:250
Cell Signaling Technology SOX2 antibody (Cell Signalling, 3579) was used in immunocytochemistry on human samples at 1:250. Acta Naturae (2014) ncbi
rabbit monoclonal (D6D9)
  • western blot; human; 1:1000; fig 1c
Cell Signaling Technology SOX2 antibody (Cell Signaling, D6D9) was used in western blot on human samples at 1:1000 (fig 1c). Int J Exp Pathol (2014) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; 1:1000
Cell Signaling Technology SOX2 antibody (Cell Signaling Technology, 2748) was used in immunohistochemistry on mouse samples at 1:1000. J Neurosci (2014) ncbi
mouse monoclonal (L1D6A2)
  • immunocytochemistry; mouse
Cell Signaling Technology SOX2 antibody (Cell Signalling, 4900) was used in immunocytochemistry on mouse samples . PLoS ONE (2014) ncbi
rabbit monoclonal (D6D9)
  • flow cytometry; human
Cell Signaling Technology SOX2 antibody (Cell Signaling, 3579) was used in flow cytometry on human samples . Cell Death Dis (2013) ncbi
rabbit monoclonal (D6D9)
  • immunohistochemistry - paraffin section; human; 1:50
Cell Signaling Technology SOX2 antibody (Cell Signaling Technologies, 3579) was used in immunohistochemistry - paraffin section on human samples at 1:50. Oncotarget (2013) ncbi
mouse monoclonal (L73B4)
  • western blot; human
Cell Signaling Technology SOX2 antibody (Cell Signaling Technology, L73B4) was used in western blot on human samples . Cancer Res (2013) ncbi
Articles Reviewed
  1. Modic M, Grosch M, Rot G, Schirge S, Lepko T, Yamazaki T, et al. Cross-Regulation between TDP-43 and Paraspeckles Promotes Pluripotency-Differentiation Transition. Mol Cell. 2019;74:951-965.e13 pubmed publisher
  2. Wang J, Xu S, Duan J, Yi L, Guo Y, Shi Y, et al. Invasion of white matter tracts by glioma stem cells is regulated by a NOTCH1-SOX2 positive-feedback loop. Nat Neurosci. 2019;22:91-105 pubmed publisher
  3. Metzis V, Steinhauser S, Pakanavicius E, Gouti M, Stamataki D, Ivanovitch K, et al. Nervous System Regionalization Entails Axial Allocation before Neural Differentiation. Cell. 2018;175:1105-1118.e17 pubmed publisher
  4. Weltner J, Balboa D, Katayama S, Bespalov M, Krjutskov K, Jouhilahti E, et al. Human pluripotent reprogramming with CRISPR activators. Nat Commun. 2018;9:2643 pubmed publisher
  5. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  6. Kogut I, McCarthy S, Pavlova M, Astling D, Chen X, Jakimenko A, et al. High-efficiency RNA-based reprogramming of human primary fibroblasts. Nat Commun. 2018;9:745 pubmed publisher
  7. Wu X, Dao Thi V, Huang Y, Billerbeck E, Saha D, Hoffmann H, et al. Intrinsic Immunity Shapes Viral Resistance of Stem Cells. Cell. 2018;172:423-438.e25 pubmed publisher
  8. Jin L, Vu T, Yuan G, Datta P. STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH Pathway. Cancer Res. 2017;77:5464-5478 pubmed publisher
  9. Shi Y, Ping Y, Zhou W, He Z, Chen C, Bian B, et al. Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth. Nat Commun. 2017;8:15080 pubmed publisher
  10. Chatzeli L, Gaete M, Tucker A. Fgf10 and Sox9 are essential for the establishment of distal progenitor cells during mouse salivary gland development. Development. 2017;144:2294-2305 pubmed publisher
  11. Yoon C, Cho S, Chang K, Park D, Ryeom S, Yoon S. Role of Rac1 Pathway in Epithelial-to-Mesenchymal Transition and Cancer Stem-like Cell Phenotypes in Gastric Adenocarcinoma. Mol Cancer Res. 2017;15:1106-1116 pubmed publisher
  12. Zhang C, Mukherjee S, Tucker Burden C, Ross J, Chau M, Kong J, et al. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3. Mol Oncol. 2017;11:280-294 pubmed publisher
  13. Bharathan S, Manian K, Aalam S, Palani D, Deshpande P, Pratheesh M, et al. Systematic evaluation of markers used for the identification of human induced pluripotent stem cells. Biol Open. 2017;6:100-108 pubmed publisher
  14. Xiao Y, Ma H, Wan P, Qin D, Wang X, Zhang X, et al. Trp-Asp (WD) Repeat Domain 1 Is Essential for Mouse Peri-implantation Development and Regulates Cofilin Phosphorylation. J Biol Chem. 2017;292:1438-1448 pubmed publisher
  15. Katsushima K, Natsume A, Ohka F, Shinjo K, Hatanaka A, Ichimura N, et al. Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment. Nat Commun. 2016;7:13616 pubmed publisher
  16. Sareddy G, Viswanadhapalli S, Surapaneni P, Suzuki T, Brenner A, Vadlamudi R. Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway. Oncogene. 2017;36:2423-2434 pubmed publisher
  17. Zeltner N, Fattahi F, Dubois N, Saurat N, Lafaille F, Shang L, et al. Capturing the biology of disease severity in a PSC-based model of familial dysautonomia. Nat Med. 2016;22:1421-1427 pubmed publisher
  18. Tahmasebi S, Jafarnejad S, Tam I, Gonatopoulos Pournatzis T, Matta Camacho E, Tsukumo Y, et al. Control of embryonic stem cell self-renewal and differentiation via coordinated alternative splicing and translation of YY2. Proc Natl Acad Sci U S A. 2016;113:12360-12367 pubmed
  19. Koch K, Hartmann R, Schröter F, Suwala A, Maciaczyk D, Krüger A, et al. Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells. Oncotarget. 2016;7:73414-73431 pubmed publisher
  20. Lee E, Wang J, Yumoto K, Jung Y, Cackowski F, Decker A, et al. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis. Neoplasia. 2016;18:553-66 pubmed publisher
  21. Magown P, Brownstone R, Rafuse V. Tumor prevention facilitates delayed transplant of stem cell-derived motoneurons. Ann Clin Transl Neurol. 2016;3:637-49 pubmed publisher
  22. Lv D, Yu S, Ping Y, Wu H, Zhao X, Zhang H, et al. A three-dimensional collagen scaffold cell culture system for screening anti-glioma therapeutics. Oncotarget. 2016;7:56904-56914 pubmed publisher
  23. Mansouri S, Singh S, Alamsahebpour A, Burrell K, Li M, Karabork M, et al. DICER governs characteristics of glioma stem cells and the resulting tumors in xenograft mouse models of glioblastoma. Oncotarget. 2016;7:56431-56446 pubmed publisher
  24. Pinet S, Bessette B, Vedrenne N, Lacroix A, Richard L, Jauberteau M, et al. TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells. Oncotarget. 2016;7:50349-50364 pubmed publisher
  25. Jung J, Kang K, Kim J, Hong S, Park Y, Kim B. CXCR2 Inhibition in Human Pluripotent Stem Cells Induces Predominant Differentiation to Mesoderm and Endoderm Through Repression of mTOR, ?-Catenin, and hTERT Activities. Stem Cells Dev. 2016;25:1006-19 pubmed publisher
  26. Langer D, Martianov I, Alpern D, Rhinn M, Keime C, Dolle P, et al. Essential role of the TFIID subunit TAF4 in murine embryogenesis and embryonic stem cell differentiation. Nat Commun. 2016;7:11063 pubmed publisher
  27. Francis K, Ton A, Xin Y, O Halloran P, Wassif C, Malik N, et al. Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/β-catenin defects in neuronal cholesterol synthesis phenotypes. Nat Med. 2016;22:388-96 pubmed publisher
  28. Ananthula S, Sinha A, El Gassim M, Batth S, Marshall G, Gardner L, et al. Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers. Oncotarget. 2016;7:20869-89 pubmed publisher
  29. Stanford E, Wang Z, Novikov O, Mulas F, Landesman Bollag E, Monti S, et al. The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells. BMC Biol. 2016;14:20 pubmed publisher
  30. Ren C, Ren T, Yang K, Wang S, Bao X, Zhang F, et al. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway. J Exp Clin Cancer Res. 2016;35:44 pubmed publisher
  31. Xu M, Bian S, Li J, He J, Chen H, Ge L, et al. MeCP2 suppresses LIN28A expression via binding to its methylated-CpG islands in pancreatic cancer cells. Oncotarget. 2016;7:14476-85 pubmed publisher
  32. Gerashchenko B, Salmina K, Eglitis J, Huna A, Grjunberga V, Erenpreisa J. Disentangling the aneuploidy and senescence paradoxes: a study of triploid breast cancers non-responsive to neoadjuvant therapy. Histochem Cell Biol. 2016;145:497-508 pubmed publisher
  33. Murakami K, Günesdogan U, Zylicz J, Tang W, Sengupta R, Kobayashi T, et al. NANOG alone induces germ cells in primed epiblast in vitro by activation of enhancers. Nature. 2016;529:403-407 pubmed publisher
  34. Joseph J, van Roosmalen I, Busschers E, Tomar T, Conroy S, Eggens Meijer E, et al. Serum-Induced Differentiation of Glioblastoma Neurospheres Leads to Enhanced Migration/Invasion Capacity That Is Associated with Increased MMP9. PLoS ONE. 2015;10:e0145393 pubmed publisher
  35. Vijaya Chandra S, Makhija H, Peter S, Myint Wai C, Li J, Zhu J, et al. Conservative site-specific and single-copy transgenesis in human LINE-1 elements. Nucleic Acids Res. 2016;44:e55 pubmed publisher
  36. Wongtrakoongate P, Riddick G, Fucharoen S, Felsenfeld G. Association of the Long Non-coding RNA Steroid Receptor RNA Activator (SRA) with TrxG and PRC2 Complexes. PLoS Genet. 2015;11:e1005615 pubmed publisher
  37. Kuo H, Hsu H, Chen Y, Chang Y, Liu F, Wu C. Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer. Glycobiology. 2016;26:155-65 pubmed publisher
  38. Balboa D, Weltner J, Eurola S, Trokovic R, Wartiovaara K, Otonkoski T. Conditionally Stabilized dCas9 Activator for Controlling Gene Expression in Human Cell Reprogramming and Differentiation. Stem Cell Reports. 2015;5:448-59 pubmed publisher
  39. Bora Singhal N, Perumal D, Nguyen J, Chellappan S. Gli1-Mediated Regulation of Sox2 Facilitates Self-Renewal of Stem-Like Cells and Confers Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer. Neoplasia. 2015;17:538-51 pubmed publisher
  40. Kegler K, Spitzbarth I, Imbschweiler I, Wewetzer K, Baumgärtner W, Seehusen F. Contribution of Schwann Cells to Remyelination in a Naturally Occurring Canine Model of CNS Neuroinflammation. PLoS ONE. 2015;10:e0133916 pubmed publisher
  41. Huna A, Salmina K, Erenpreisa J, Vazquez Martin A, Krigerts J, Inashkina I, et al. Role of stress-activated OCT4A in the cell fate decisions of embryonal carcinoma cells treated with etoposide. Cell Cycle. 2015;14:2969-84 pubmed publisher
  42. Zucha M, Wu A, Lee W, Wang L, Lin W, Yuan C, et al. Bruton's tyrosine kinase (Btk) inhibitor ibrutinib suppresses stem-like traits in ovarian cancer. Oncotarget. 2015;6:13255-68 pubmed
  43. Di Cristofori A, Ferrero S, Bertolini I, Gaudioso G, Russo M, Berno V, et al. The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma. Oncotarget. 2015;6:17514-31 pubmed
  44. Machado C, Griesi Oliveira K, Rosenberg C, Kok F, Martins S, Passos Bueno M, et al. Collybistin binds and inhibits mTORC1 signaling: a potential novel mechanism contributing to intellectual disability and autism. Eur J Hum Genet. 2016;24:59-65 pubmed publisher
  45. Driscoll C, Tonne J, El Khatib M, Cattaneo R, Ikeda Y, Devaux P. Nuclear reprogramming with a non-integrating human RNA virus. Stem Cell Res Ther. 2015;6:48 pubmed publisher
  46. Jung K, Gupta N, Wang P, Lewis J, Gopal K, Wu F, et al. Triple negative breast cancers comprise a highly tumorigenic cell subpopulation detectable by its high responsiveness to a Sox2 regulatory region 2 (SRR2) reporter. Oncotarget. 2015;6:10366-73 pubmed
  47. Costabile V, Duraturo F, Delrio P, Rega D, Pace U, Liccardo R, et al. Lithium chloride induces mesenchymal‑to‑epithelial reverting transition in primary colon cancer cell cultures. Int J Oncol. 2015;46:1913-23 pubmed publisher
  48. Peretz Y, Wu H, Patel S, Bellacosa A, Katz R. Inhibitor of DNA Binding 4 (ID4) is highly expressed in human melanoma tissues and may function to restrict normal differentiation of melanoma cells. PLoS ONE. 2015;10:e0116839 pubmed publisher
  49. Ma R, Latif R, Davies T. Human embryonic stem cells form functional thyroid follicles. Thyroid. 2015;25:455-61 pubmed publisher
  50. Weissferdt A, Rodriguez Canales J, Liu H, Fujimoto J, Wistuba I, Moran C. Primary mediastinal seminomas: a comprehensive immunohistochemical study with a focus on novel markers. Hum Pathol. 2015;46:376-83 pubmed publisher
  51. Geula S, Moshitch Moshkovitz S, Dominissini D, Mansour A, Kol N, Salmon Divon M, et al. Stem cells. m6A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation. Science. 2015;347:1002-6 pubmed publisher
  52. Hoefflin S, Carter D. Neuronal expression of SOX2 is enriched in specific hypothalamic cell groups. J Chem Neuroanat. 2014;61-62:153-60 pubmed publisher
  53. Jia D, Yang W, Li L, Liu H, Tan Y, Ooi S, et al. β-Catenin and NF-κB co-activation triggered by TLR3 stimulation facilitates stem cell-like phenotypes in breast cancer. Cell Death Differ. 2015;22:298-310 pubmed publisher
  54. Holmberg Olausson K, Maire C, Haidar S, Ling J, Learner E, Nistér M, et al. Prominin-1 (CD133) defines both stem and non-stem cell populations in CNS development and gliomas. PLoS ONE. 2014;9:e106694 pubmed publisher
  55. Ma M, Czepiel M, Krause T, Schafer K, Boddeke E, Copray S. Generation of induced pluripotent stem cells from hair follicle bulge neural crest stem cells. Cell Reprogram. 2014;16:307-13 pubmed publisher
  56. Yu D, Swaroop M, Wang M, Baxa U, Yang R, Yan Y, et al. Niemann-Pick Disease Type C: Induced Pluripotent Stem Cell-Derived Neuronal Cells for Modeling Neural Disease and Evaluating Drug Efficacy. J Biomol Screen. 2014;19:1164-73 pubmed publisher
  57. Muchkaeva I, Dashinimaev E, Artyuhov A, Myagkova E, Vorotelyak E, Yegorov Y, et al. Generation of iPS Cells from Human Hair Follice Dermal Papilla Cells. Acta Naturae. 2014;6:45-53 pubmed
  58. Mouallif M, Albert A, Zeddou M, Ennaji M, Delvenne P, Guenin S. Expression profile of undifferentiated cell transcription factor 1 in normal and cancerous human epithelia. Int J Exp Pathol. 2014;95:251-9 pubmed publisher
  59. Piper M, Barry G, Harvey T, McLeay R, Smith A, Harris L, et al. NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical development. J Neurosci. 2014;34:2921-30 pubmed publisher
  60. Martianov I, Cler E, Duluc I, Vicaire S, Philipps M, Freund J, et al. TAF4 inactivation reveals the 3 dimensional growth promoting activities of collagen 6A3. PLoS ONE. 2014;9:e87365 pubmed publisher
  61. Liu H, Zhang W, Jia Y, Yu Q, Grau G, Peng L, et al. Single-cell clones of liver cancer stem cells have the potential of differentiating into different types of tumor cells. Cell Death Dis. 2013;4:e857 pubmed publisher
  62. Mao X, Hütt Cabezas M, Orr B, Weingart M, Taylor I, Rajan A, et al. LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program. Oncotarget. 2013;4:1050-64 pubmed
  63. Camps J, Pitt J, Emons G, Hummon A, Case C, Grade M, et al. Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT/β-catenin pathway in colorectal cancer. Cancer Res. 2013;73:2003-13 pubmed publisher